Ngenla 60 mg/1.2mL (Somatrogon-Ghla INJECTION, SOLUTION) 60 mg/1.2mL

Ngenla 60 mg/1.2mL is a somatrogon-ghla injection solution used for growth hormone therapy. This subcutaneous injection is designed to support growth in children with growth hormone deficiency.

Strength

60 mg/1.2mL

Pack Size

1 CARTRIDGE in 1 CARTON (0069-0520-02) / 1.2 mL in 1 CARTRIDGE (0069-0520-01)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ngenla 60 mg/1.2mL is primarily used for growth hormone therapy in children who have growth hormone deficiency. This medication helps to promote growth and development in children who are not growing properly due to a lack of natural growth hormone. It is important to use this medication as directed by a healthcare provider.

Side Effects

Common effects of Ngenla 60 mg/1.2mL may include redness, swelling, or itching at the injection site. Some users may also experience headaches, muscle pain, or joint pain. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider.

Precautions & Warnings

Ngenla 60 mg/1.2mL should be handled with care and stored as directed. It is important to follow the instructions provided by the healthcare provider for proper administration. This medication should not be used if the solution appears cloudy or contains particles. Always check the expiration date before use.

Avoid Interactions

Ngenla 60 mg/1.2mL may interact with other medications, including those that affect growth hormone levels. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements. Alcohol and certain foods may also affect the effectiveness of this medication.

Frequently Asked Questions

Ngenla 60 mg/1.2mL is used for growth hormone therapy in children with growth hormone deficiency.

Ngenla 60 mg/1.2mL is administered subcutaneously, typically by injection. Follow the instructions provided by your healthcare provider.

Common side effects may include redness, swelling, or itching at the injection site, headaches, muscle pain, or joint pain.

Ngenla 60 mg/1.2mL may interact with other medications. Consult your healthcare provider before combining it with other treatments.

Store Ngenla 60 mg/1.2mL as directed by the manufacturer, typically in a cool, dry place away from direct sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.